top of page

Prokarium's CEO explains how the company is harnessing bacteria as a therapy, and in the future as a deliverer of therapies

Apr 29, 2024
1 min read

Kristen Albright describes Prokarium's bladder cancer program, which went into the clinic earlier this year, and a platform (including a partnership with Ginkgo) that is designed to use bacteria to deliver therapeutic payloads.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page